Revised CMS guidance on informed consent for psychotropic medications emphasizes the resident's right to be fully informed and the right to accept or...
To meet CMS F605 guidelines, prescribing a psychotropic drug requires an “adequate indication for use”. Current practices in neuropharmacology provide...
Under recently revised CMS guidance for nursing homes, F605 imposes new requirements for nursing home staff who are managing aggressive behaviors in r...
For nursing home residents living with dementia, wandering behavior is common. Up to 70% will have at least one episode.
New CMS guidance for surveyors in long-term care aims to prevent the unnecessary use of psychotropic medications. It calls for scrutiny of any situati...
As revised CMS guidance takes hold in skilled nursing facilities, a heightened focus on diagnosis underlying the use of psychotropic medications is es...
For nursing home residents who are living with dementia, conversations can become challenging. Here are some insights and ideas that can help staff an...
New research published in JAMA Neurology identifies common risk factors for late-onset epilepsy among people living with dementia or cognitive decline...
Nursing home residents living with dementia are at heightened risk of hospitalization. These hospitalizations incur estimated healthcare costs of $2.6...
The clinical outcomes for about 95% of long-term care residents living with dementia could be improved by applying longstanding research to the bedsid...
CMS, in its new guidance for long-term care surveyors now taking effect on April 28, 2025, specifies practices for Gradual Dose Reduction (GDR) for re...
Steven L. Posar, MD, GuideStar CEO and Founder, was recently a guest on a Gerontological Advanced Practice Nurses Association production, the GAPNA Ch...
